Bristol-Myers Squibb has formed an R&D partnership with GentiBio, aimed at developing regulatory T cel (Treg) therapies for inflammatory bowel disease (IBD). The deal includes an undisclosed upfront ...
To understand how other health problems can look like IBD, it helps to understand the differences between the two main types of IBD. For example, while Crohn’s and UC can both cause diarrhea, bleeding ...
The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two decades. Historically, therapeutic strategies primarily focused on suppressing ...
IBD/TIPP Economic Optimism 51.7 vs. 53.2 forecast By Investing.com - Apr 04, 2017 Investing.com - The IBD/TIPP economic optimism index rose less-than-expected last month, official data showed on ...
Inflammatory bowel disease is a chronic condition of unknown origin characterized by severe inflammation and mucosal destruction in the intestine. There are two main forms: Crohn s disease, which can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results